Citations for
1CYFIP2, NUAK2
NUAK2 silencing inhibits the proliferation, migration and epithelial‑to‑mesenchymal transition of cervical cancer cells via upregulating CYFIP2
Li Y, Song X, Liu L, Yue L.
Mol Med Rep. Nov;24(5):817. doi: 10.3892/mmr.2021.12457. Epub 2021 Sep 24. 2021
2CYFIP2, NCKAP1, NDDAID
NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism
Guo H, Zhang Q, Dai R, Yu B, Hoekzema K, Tan J, Tan S, Jia X, Chung WK, Hernan R, Alkuraya FS, Alsulaiman A, Al-Muhaizea MA, Lesca G, Pons L, Labalme A, Laux L, Bryant E, Brown NJ, Savva E, Ayres S, Eratne D, Peeters H, Bilan F, Letienne-Cejudo L, Gilbert-Dussardier B, Ruiz-Arana IL, Merlini JM, Boizot A, Bartoloni L, Santoni F, Karlowicz D, McDonald M, Wu H, Hu Z, Chen G, Ou J, Brasch-Andersen C, Fagerberg CR, Dreyer I, Chun-Hui Tsai A, Slegesky V, McGee RB, Daniels B, Sellars EA, Carpenter LA, Schaefer B, Sacoto MJG, Begtrup A, Schnur RE, Punj S, Wentzensen IM, Rhodes L, Pan Q, Bernier RA, Chen C, Eichler EE, Xia K.
Am J Hum Genet. Nov 5;107(5):963-976. doi: 10.1016/j.ajhg.2020.10.002. 2020
3CYFIP2, EIEE65, NCKAP1
Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.
Zweier M, Begemann A, McWalter K, Cho MT, Abela L, Banka S, Behring B, Berger A, Brown CW, Carneiro M, Chen J, Cooper GM; Deciphering Developmental Disorders (DDD) Study, Finnila CR, Guillen Sacoto MJ, Henderson A, Hüffmeier U, Joset P, Kerr B, Lesca G, Leszinski GS, McDermott JH, Meltzer MR, Monaghan KG, Mostafavi R, Ġunap K, Plecko B, Powis Z, Purcarin G, Reimand T, Riedhammer KM, Schreiber JM, Sirsi D, Wierenga KJ, Wojcik MH, Papuc SM, Steindl K, Sticht H, Rauch A.
Eur J Hum Genet. May;27(5):747-759. doi: 10.1038/s41431-018-0331-z. Epub 2019 Jan 21 2019
4CYFIP1, CYFIP2
Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism.
Noroozi R, Omrani MD, Sayad A, Taheri M, Ghafouri-Fard S.
Metab Brain Dis etab Brain Dis. 2018 May 11. doi: 10.1007/s11011-018-0249-8. [Epub ahead of print] 2018
5CYFIP2
A Cyfip2-Dependent Excitatory Interneuron Pathway Establishes the Innate Startle Threshold.
Marsden KC, Jain RA, Wolman MA, Echeverry FA, Nelson JC, Hayer KE, Miltenberg B, Pereda AE, Granato M.
Cell Rep 23(3):878-887. doi: 10.1016/j.celrep.2018.03.095. 2018
6CYFIP2, EIEE65
De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy.
Nakashima M, Kato M, Aoto K, Shiina M, Belal H, Mukaida S, Kumada S, Sato A, Zerem A, Lerman-Sagie T, Lev D, Leong HY, Tsurusaki Y, Mizuguchi T, Miyatake S, Miyake N, Ogata K, Saitsu H, Matsumoto N.
Ann Neurol 83(4):794-806. doi: 10.1002/ana.25208. 2018
7CYFIP2
Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.
Kirkpatrick SL, Goldberg LR, Yazdani N, Babbs RK, Wu J, Reed ER, Jenkins DF, Bolgioni AF, Landaverde KI, Luttik KP, Mitchell KS, Kumar V, Johnson WE, Mulligan MK, Cottone P, Bryant CD.
Biol Psychiatry 81(9):757-769. doi: 10.1016/j.biopsych.2016.10.021. Epub 2016 Oct 25. 2017
8CYFIP2
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.
Tiwari SS, Mizuno K, Ghosh A, Aziz W, Troakes C, Daoud J, Golash V, Noble W, Hortobágyi T, Giese KP.
Brain 139(Pt 10):2751-2765. Epub 2016 Aug 14. 2016
9CYFIP2
Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K, Chen H, Gennarino VA, Richman R, Lu HC, Zoghbi HY.
Hum Mol Genet 24(7):1813-23. doi: 10.1093/hmg/ddu595. Epub 2014 Nov 28. 2015
10CYFIP2, RBBP9
Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis.
Nachmany H, Wald S, Abekasis M, Bulvik S, Weil M.
Dis Markers 32(4):211-20. doi: 10.3233/DMA-2011-0885. 2012
11CYFIP2
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, Whelan AM, Zukin RS, Klann E, Tassone F.
Genes Brain Behav 11(3):332-41. doi: 10.1111/j.1601-183X.2012.00768.x. Epub 2012 Feb 15. 2012
12CYFIP2
CYFIP2, a direct p53 target, is leptomycin-B sensitive.
Jackson RS 2nd, Cho YJ, Stein S, Liang P.
Cell Cycle 6(1):95-103. Epub 2007 Jan 29. 2007
13CYFIP1, CYFIP2, FMR1
A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.
Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL.
Proc Natl Acad Sci U S A 98(15):8844-9. 2001